Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=tsptLatest Financial News for Transcept Pharmaceuticals, Inc.en-usFri, 18 Dec 2009 05:00:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/smallcapinvestor/091218/18467.html?.v=1yahoo_finance/847205052Fri, 18 Dec 2009 05:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/tspt8-k.htmlyahoo_finance/4118590561Tue, 15 Dec 2009 19:11:04 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091214/sf25600.html?.v=1Transcept Pharmaceuticals, Inc. today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for claims under U.S. patent application no. 11/060,641, which covers the composition and use of Intermezzo® , the lead Transcept product candidate.  Once issued, this patent will expire no earlier than February 2025.yahoo_finance/1106013602Mon, 14 Dec 2009 21:35:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/tm/091201/51355.html?.v=3Looking to turn a profit when things are going bearish? Here, we highlight a short side play with these two PowerRatings stocks that has been hit by sector weakness.yahoo_finance/4249604861Tue, 1 Dec 2009 14:35:43 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=136q89de3/*http%3A//seekingalpha.com/article/175899-somaxon-pharmaceuticals-fda-close-to-a-decision-for-silenor?source=yahooyahoo_finance/3027670841Tue, 1 Dec 2009 13:32:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091124/tspt8-k.htmlyahoo_finance/1828633432Tue, 24 Nov 2009 18:56:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12vfh08s3/*http%3A//seekingalpha.com/article/175063-biomed-news-bytes-transcept-prourocare-sciclone-abio?source=yahooyahoo_finance/3857889187Tue, 24 Nov 2009 15:31:36 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091123/sf15785.html?.v=1Transcept Pharmaceuticals, Inc. today announced that it is scheduled to meet with the U.S. Food and Drug Administration on January 20, 2010 to discuss the Complete Response Letter regarding the New Drug Application for Intermezzo® .yahoo_finance/2699334876Mon, 23 Nov 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=tsptyahoo_finance/3982143487Fri, 20 Nov 2009 18:04:47 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091119/tspt8-k_a.htmlyahoo_finance/3282972200Thu, 19 Nov 2009 20:02:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091116/tspt10-q.htmlyahoo_finance/794271866Mon, 16 Nov 2009 21:49:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/t/tspt.htmlyahoo_finance/1610082976Sun, 15 Nov 2009 14:21:43 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12l2m8k59/*http%3A//sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/11/09/daily103.html?ana=yfcpcyahoo_finance/1362288553Thu, 12 Nov 2009 23:05:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091112/tspt8-k.htmlyahoo_finance/1283469781Thu, 12 Nov 2009 21:24:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091112/sf10382.html?.v=1Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the three and nine months ended September 30, 2009.yahoo_finance/3798964136Thu, 12 Nov 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091112.html?t=tsptyahoo_finance/486421999Thu, 12 Nov 2009 12:07:30 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091110/sf08805.html?.v=1Transcept Pharmaceuticals, Inc.yahoo_finance/392762747Tue, 10 Nov 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091105/sf06565.html?.v=1Transcept Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will host a webcast and teleconference with management to discuss third quarter 2009 financial results on Thursday, November 12, 2009, at 5:00 p.m.yahoo_finance/3419595568Thu, 5 Nov 2009 22:34:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091104/tspt8-k.htmlyahoo_finance/3650024090Wed, 4 Nov 2009 21:47:12 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091104/sf05041.html?.v=1yahoo_finance/2406270723Wed, 4 Nov 2009 12:05:00 Etc/GMT